Midday movers: Lululemon, Paramount and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
bluebird bio (BLUE) shares rally as Morgan Stanley believes lovo-cel likely to be approved by December PDUFA date
December 8, 2023 10:20 AM ESTbluebird bio (NASDAQ: BLUE) shares jumped Friday after Morgan Stanley analyst Jeffrey Hung raised the stock to Equal-Weight from Underweight, lifting the price target to $7 from $3 per share.
BLUE shares are up more than 11% at the time of writing, trading at around... More
